Key result
Mitral valve replacement with a Starr-Edwards prosthesis caused chronic intravascular hemolysis in 85% of patients, compared to no comparable evidence in those receiving an aortic homograft.
Why the study?
Does mitral valve replacement with a Starr-Edwards prosthesis increase chronic intravascular hemolysis compared to an aortic homograft in patients undergoing mitral valve replacement?
Cohort (n=41)
Does mitral valve replacement with a Starr-Edwards prosthesis increase chronic intravascular hemolysis compared to an aortic homograft in patients undergoing mitral valve replacement?
Mitral valve replacement with a Starr-Edwards prosthesis is associated with a significantly higher incidence of chronic intravascular hemolysis compared to a gamma-radiated aortic homograft.
Answers are grounded in this paper and cite their sources.
Starr-Edwards mitral replacement was associated with chronic hemolysis; leaves open relevance to contemporary mechanical valves.
The incidence and severity of chronic intravascular hemolysis was evaluated in a total of 41 patients following mitral valve replacement. Valve replacement was with a gamma-radiated frame-mounted aortic homograft in 21 patients and with a composite seat Starr-Edwards prosthesis, model 6310 or 6320, in 20 patients. The parameters used to assess hemolysis were hemoglobin, hematocrit, reticulocyte count, red cell fragment count, serum haptoglobin, LDH and HBD, hemosiderin in the urine and red cell survival. The degree of hemolysis was classified as mild, moderate or severe. In the prosthetic valve group 85% showed evidence of chronic intravascular hemolysis, of which a third were mild and the rest moderate. The homograft patients did not show any comparable evidence of hemolysis. Statistical analysis of the comparative figures of the parameters used to assess hemolysis in the two groups of patients revealed a significant difference ( P < 0.01) in hemoglobin and hematocrit and a highly significant difference ( P < .001) in serum haptoglobins, hemosiderin in the urine, LDH, reticulocyte count, red cell fragment count and red cell survivals.
No takes yet. Share an insight, caveat, or question.
Donnelly et al. (1973) conducted a cohort in Mitral valve replacement (n=41). Composite seat Starr-Edwards prosthesis vs. Gamma-radiated frame-mounted aortic homograft was evaluated on Evidence of chronic intravascular hemolysis (p=<0.001). Mitral valve replacement with a Starr-Edwards prosthesis caused chronic intravascular hemolysis in 85% of patients, compared to no comparable evidence in those receiving an aortic homograft.
Synapse has enriched 10 related papers. Consider them for comparative context: